Morning Digest: WHO to provide 120 million rapid COVID-19 tests to poorer countries, States told to strengthen security ahead of Babri verdict, and more

A select list of stories to read before you start your day. WHO says 120 million rapid COVID-19 tests to be provided to poorer countries Some 120 million rapid diagnostic tests for coronavirus will be made available to low- and middle-income countries at a maximum of $5 each, the World …

Read moreMorning Digest: WHO to provide 120 million rapid COVID-19 tests to poorer countries, States told to strengthen security ahead of Babri verdict, and more

Bullish on long-term growth story of domestic auto industry despite hiccups: Maruti Suzuki

The country’s largest carmaker Maruti Suzuki India (MSI) remains bullish on the long-term growth prospects of the domestic automobile industry despite challenges in the short-term, a senior company official has said. The auto major, which has close to 50 per cent market share in the domestic passenger vehicle segment, noted …

Read moreBullish on long-term growth story of domestic auto industry despite hiccups: Maruti Suzuki

Life after Covid: For survivors, reinfection and health complications are becoming causes for concern

It is a bright Wednesday morning in the second week of September and about a dozen men and women wait in a Covid-appropriate queue to see a doctor at RML Hospital in New Delhi. All of them have one thing in common: they have beaten the Covid-19 virus. But that …

Read moreLife after Covid: For survivors, reinfection and health complications are becoming causes for concern

Post-Covid ailments may last for life: Dr Randeep Guleria, Pulmonology specialist and AIIMS Director

Pulmonology specialist and AIIMS Director Randeep Guleria is at the forefront of anti-Covid treatment in the country. He tells ET Magazine that reinfection is a reality now and a lot of research is being done to understand it. Edited excerpts of the interview: More people have started complaining about post-Covid …

Read morePost-Covid ailments may last for life: Dr Randeep Guleria, Pulmonology specialist and AIIMS Director

Will govt have Rs 80,000 cr for distribution of vaccine, asks Serum Institute CEO

Pune: Adar Poonawalla, Chief Executive Officer of Serum Institute of India (SII) which is producing the potential coronavirus vaccine developed by Oxford University, asked on Saturday if the government will have Rs 80,000 crore available to buy and distribute the vaccine. “Quick question; will the government of India have 80,000 …

Read moreWill govt have Rs 80,000 cr for distribution of vaccine, asks Serum Institute CEO

Majority of retailers expect festive season biz to be down by 25 per cent: Report

New Delhi: A majority of retailers expect festive season business this year to be down by 25 per cent compared to last year due to the impact of coronavirus pandemic and many of them are considering cancelling or deferring orders due to reduced festive forecasts, according to a report by …

Read moreMajority of retailers expect festive season biz to be down by 25 per cent: Report

Post Covid, North East would be hub for tourism: Union Minister Dr Jitendra Singh

GUWAHATI: DoNER minister Dr Jitendra Singh said the post COVID, Northeast would have a lot more to offer and being relatively unaffected by the pandemic, the North Eastern region would be hub for the tourist who used to visit European resorts for holidays. The launch of theme song and logo …

Read morePost Covid, North East would be hub for tourism: Union Minister Dr Jitendra Singh

Movie channels look at direct-to-TV films, big premieres to fight OTT

NEW DELHI: Indian movie channels are looking at a mix of direct-to-television films and quick premieres of popular and niche movies to scale up viewership acquired during the pandemic-lockdown, helping them fight the relatively more popular and emerging streaming platforms. Earlier this month, Zee Entertainment Enterprises Ltd launched its pay-per-view …

Read moreMovie channels look at direct-to-TV films, big premieres to fight OTT

To get approval in India, vaccines must work in at least 50% cases

Mumbai: Companies working on Covid-19 vaccine in India will have to demonstrate that at least half the people who receive it are protected from the infection and that it induces superior antibody and cellular responses to get their vaccine approved. Vaccines developed outside of India can apply for marketing authorisation …

Read moreTo get approval in India, vaccines must work in at least 50% cases

Sundaram Bluechip Fund: Sundaram Mutual launches Sundaram Bluechip Fund

Sundaram Mutual has announced the launch of Sundaram Bluechip Fund on Wednesday. The New Fund Offer (NFO) is an open-ended equity scheme predominantly investing in large cap bluechip stocks. The NFO will open for subscription on September 17, and close on September 30. The scheme will reopen for ongoing subscription …

Read moreSundaram Bluechip Fund: Sundaram Mutual launches Sundaram Bluechip Fund